We use cookies to make your visit to our website as pleasant as possible. If you continue to use the website, you agree to our privacy policy and to the use of cookies. More information about cookies and how ImpediMed uses them is available here.
Accept Cookies
THE PREVENT TRIAL
Stopping Lymphedema Starts with PREVENT - Final 3-Year Primary Endpoint Results Published
See the Results
X
Impedimed Logo
  • Products
    • SOZO® Digital Health Platform
    • SOZO® Applications
      • L-Dex® Analysis for Lymphedema
      • BodyComp™ Analysis
      • Segmental BodyComp™ Analysis
      • HF-Dex™ Analysis for Heart Failure
      • Request SOZO® Demo
    • Research Devices
      • SFB7
      • ImpediVET
    • Technology
      • What is BIS?
    • Specialty
      • Lymphedema Prevention Program
      • Heart Failure Early Adopter Program
  • Patients
    • Find an L-Dex® Provider
    • Preventing Lymphedema
    • Managing Heart Failure
  • Resources & Support
    • Resources
      • The PREVENT Trial
      • Clinical Evidence
      • What is BIS?
      • What is L-Dex® Score
      • Privacy & Security
      • Reimbursement
      • Webinars & Events
    • Knowledge Center
      • Videos
      • Device Set-up & Use
      • Software User Guides
      • L-Dex® Analysis for Lymphedema
      • BodyComp™ Analysis
      • Segmental BodyComp™ Analysis
      • HF-Dex™ Analysis for Heart Failure
      • Lymphedema Prevention Program
    • Support
      • Frequently Asked Questions
      • IFU Documents
      • Quality & Regulatory Certificates
      • Discontinued Products
      • Register Your Product
      • Request Support
  • About
    • Careers
    • Investor Relations
    • Leadership
    • Newsroom
    • Patents
  • Request Quote
  • Find Provider
  • Investors
  • MyZOZO
  • Contact
  • Find Provider
  • Investors
  • MySOZO
  • Contact
Impedimed Logo
  • Products
    • Products
      • SOZO® Digital Health Platform
      • SOZO® Applications
        • L-Dex® Analysis for Lymphedema
        • BodyComp™ Analysis
        • Segmental BodyComp™ Analysis
        • HF-Dex™ Analysis for Heart Failure
      • Request SOZO® Demo
    • Research Devices
      • SFB7
      • ImpediVET
      • Technology
      • What is BIS?
    • Specialty
      • Oncology
      • Cardiology
      • Rehabilitation & Therapy
      • Research
      • Programs
        • Lymphedema Prevention Program
        • Heart Failure Early Adopter Program
  • Patients
    • Find Provider
    • Preventing Lymphedema
    • Managing Heart Failure
  • Resources & Support
    • Resources
      • The PREVENT Trial
      • Clinical Evidence
      • What is BIS?
      • What is the L-Dex® Score?
      • Privacy & Security
      • Reimbursement
      • Webinars & Events
    • Knowledge Center
      • Videos
      • Device Set-up & Use
      • Software User Guides
      • L-Dex® Analysis for Lymphedema
      • BodyComp™ Analysis
      • Segmental BodyComp™ Analysis
      • HF-Dex™ Analysis for Heart Failure
      • Lymphedema Prevention Program
    • Support
      • Frequently Asked Questions
      • IFU Documents
      • Quality & Regulatory Certificates
      • Terms & Conditions
      • Discontinued Products
      • Register Your Product
      • Request Support
  • About
    • Careers
    • Investor Relations
    • Leadership
    • Newsroom
    • Patents
  • Request Quote

David Anderson, BSc

Executive Director

David Anderson serves on the Board of ImpediMed as an Executive Director, in conjunction with his role as Executive Consultant, focused on the Company’s reimbursement strategy. From July 2022 – November 2022, Dave also served as Interim CEO for the Company.

David was appointed to the Board in May 2020 as a Non-Executive Director, served as the Remuneration Committee Chair and was a member of the Nomination Committee.

Prior to being appointed, David served as President and CEO of HealthNow Systems Inc, operating as Blue Cross Blue Shield (BCBS) health plans in New York State.

HealthNow operates as a licensee of the Blue Cross Blue Shield Association, which in total, provides health care services to 1 in every 3 Americans across all 50 states and US territories and is accepted at over 90% of US doctors, hospitals and other health care providers.

David is a US health care industry executive who serves on the board of the National Institute of Healthcare Management, Blue Cross Blue Shield Association board of Directors, the board of the New York State Business Council and the New York State Insurance Advisory Committee as appointed by the Commissioner of the Department of Financial Services.

Additionally, David serves as an advisor and speaker for Modern Healthcare’s CEO Power Panel and the Aspen Institute. Prior to his role at BCBS, Mr. Anderson was CEO of United Healthcare’s Southern California Health Plan. Mr. Anderson is a native of Fort Wayne, Indiana, and a graduate of Indiana University’s Kelly School of Business, with a B.S. in Finance.
  • Request Quote
  • Request Demo
  • Request Support
  • Contact
  • Linked In
  • YouTube
  • Twiiter
  • Facebook
  • Products
    • SOZO® Digital Health Platform
    • SFB7
    • ImpediVET
    • L-Dex® U400
    • DF50
    • Request Quote
  • SOZO® Applications
    • L-Dex® Analysis for Lymphedema
    • BodyComp™ Analysis
    • Segmental BodyComp™ Analysis
    • HF-Dex™ Analysis for Heart Failure
    • Request SOZO® Demo
  • Specialty
    • Oncology
    • Cardiology
    • Rehabilitation & Therapy
    • Research
    • Clinical Evidence
  • Patient Resources
    • Find Provider
    • Preventing Lymphedema
    • Lymphedema Community Resources
    • Managing Heart Failure
  • Resources & Support
    • Resources
    • The PREVENT Trial
    • Knowledge Center
    • Technical Support
    • Technical Service Bulletins
    • Webinars & Events
    • Request Support
  • About ImpediMed
    • Leadership Team
    • Investor Relations
    • Careers
    • Newsroom
    • Contact Us
Privacy Policy | Terms of Use
© 2023 All Rights Reserved. ImpediMed Limited and ImpediMed Inc.